Controlled Substances
Midlevel prescribers DEA number start with this letter.
M
Dilaudid is in this drug class.
II
A medication would be described as this if it is bioequivalent and pharmaceutically equivalent.
Therapeutic equivalent.
The DAW code used when substitution is not allowed by the prescriber is this.
DAW 1
The FDA must approve this in order for a manufacturer to bring a generic medication to market.
ANDA
Duragesic prescriptions are allowed this many refills.
0
This medication Kadian is in this drug schedule class.
II
Life threatening adverse effected medication fall under this drug recall class.
Class I
The DAW code that reflects a substitution not allowed by pharmacist is.
DAW 3
Inpatient pharmacies that treat with Fentora must be registered in this program.
TIRF
This form must be filled out when sending expired Schedule II medications to a reverse distributor.
222
Ambien is in this drug class schedule.
IV
Absorbs and releases the same in the body, describes medication as being this.
Bioequivalent
DAW 5 is the code used for this reason.
Brand name drugs being dispensed as a generic
This program monitors severe netropina.
Clozapine Rems
Controlled substance inventories must be completed this often according to federal law.
Every 2 years (Biennially)
Vimpat is in this drug class schedule.
V
Contaminated medication that causes nausea and vomiting are part of this recall class.
Class II
This DAW code used when substitution is not allowed by the state is.
DAW 7
Outpatient pharmacies must enroll in this program when dispensing fentanyl.
Transmucosal Immediate Release Fentanyl- TIRF
DEA Form 41 is required to be filled out when this needs to be done for controlled substances.
Destroyed or Disposed
The medication Lomotil is in this schedule drug class.
V
Drugs involved in adverse events are involved in this drug recall category.
Class III
DAW 4 is the code used for this reason.
Substitution not allowed because the generic is not in stock.
Isotretinoin prescriptions have do not dispense after document date that have 2 restrictions.
30 days after office visits for all patients and 7 days after a pregnancy test for females of child baring age